CAS: 177575-17-6 - N-[[5-[2-[(6S)-2-Amino-4,6,7,8-tetrahydro-4-oxo-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-L-glutamic acid

Formel: C₁₈H₂₁N₅O₆S₂

InChl: InChI=1S/C18H21N5O6S2/c19-18-22-14-13(16(27)23-18)31-9(7-20-14)2-1-8-3-5-11(30-8)15(26)21-10(17(28)29)4-6-12(24)25/h3,5,9-10H,1-2,4,6-7H2,(H,21,26)(H,24,25)(H,28,29)(H4,19,20,22,23,27)/t9-,10-/m0/s1

InChI Key: InChIKey=HHKAOUMVRGSKLS-UWVGGRQHSA-N

SMILES: O=C1N=C(N)NC=2NCC(SC12)CCC=3SC(=CC3)C(=O)NC(C(=O)O)CCC(=O)O

Synonyme:

• <span class="text-smallcaps">L</span>-Glutamic acid, N-[[5-[2-(2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]-2-thienyl]carbonyl]-, (S)-
• <span class="text-smallcaps">L</span>-Glutamic acid, N-[[5-[2-[(6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-
• <span class="text-smallcaps">L</span>-Glutamic acid, N-[[5-[2-[(6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-
• AG-2033((6R)-isomer)
• Ag-2034
• N-[(5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-1H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}thiophen-2-yl)carbonyl]-L-glutamic acid
• N-[[5-[2-[(6S)-2-Amino-4,6,7,8-tetrahydro-4-oxo-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-<span class="text-smallcaps">L</span>-glutamic acid
• N-[[5-[2-[(6S)-2-Amino-4,6,7,8-tetrahydro-4-oxo-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-L-glutamic acid
• L-Glutamic acid, N-[[5-[2-(2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]-2-thienyl]carbonyl]-, (S)-
• L-Glutamic acid, N-[[5-[2-[(6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-
• L-Glutamic acid, N-[[5-[2-[(6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]-2-thienyl]carbonyl]-

AG2034

CAS: 177575-17-6

AG2034 is a drug that is currently in development for the treatment of autoimmune diseases …

• Formel: C₁₈H₂₁N₅O₆S₂
• Reinheit: Min. 95%
• Molekulargewicht: 467.52 g/mol

AG2034

CAS: 177575-17-6

AG2034 is an inhibitor of the glycinamide ribonucleotide formyltransferase (GARFT).

• Formel: C₁₈H₂₁N₅O₆S₂
• Farbe und Form: Solid
• Molekulargewicht: 467.52